AXON

Axon Enterprise
Aerospace & Defense · Industrials · as of 2026-11-20
Last close
$304.40
-0.8% on the session
1-year return
-42.7%
-21.1% over six months
Volatility
64.4%
annualized, trailing year
Max drawdown
-53.8%
worst peak to trough, 1y
What the numbers say

Axon Enterprise is a aerospace & defense name in the industrials sector. Over the past year it returned -42.7%, against -49.1% over three months and -26.6% over one. It trades 34.2% below its 200-day average, so recent moves have not repaired the longer downtrend. Annualized volatility of 64.4% is very high, position sizing matters more here than the ranking does.

Its worst peak-to-trough decline over the year was -53.8%, and it has traded a median $402M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.31 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Industrials#81 of 81
Stronger than 0% of its sector on the momentum profile
Across the whole index#492 of 497

How AXON scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 11 others in Aerospace & Defense.

Start a free 7-day trial
Full metrics
1 day-0.8%
1 week-3.5%
1 month-26.6%
3 months-49.1%
6 months-21.1%
1 year-42.7%
12-1 momentum-21.9%
Volatility (1y, annualized)64.4%
Max drawdown (1y)-53.8%
Distance vs 200-day average-34.2%
Return per unit of risk-0.66
Median daily dollar volume$402M
Free newsletter

Get AXON when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.